CHICAGO--(BUSINESS WIRE)--A novel way of formulating a widely used class of pain medicines may allow reduced and more tolerable doses to be administered while preserving the pain-relieving effects of higher doses, according to multiple reports presented today at the annual meeting of the American College of Rheumatology (ACR).
